The trajectory of Sildenafil presents a nuanced case for stakeholders in the drug sector. While initially a tremendous success, generating huge profits, the exclusivity end and the subsequent entry of off-brand https://knockoff441783.webbuzzfeed.com/42117468/sildenafil-and-pharma-a-speculative-play